114 related articles for article (PubMed ID: 2795725)
1. Doxepin in the treatment of female detrusor overactivity: a randomized double-blind crossover study.
Lose G; Jørgensen L; Thunedborg P
J Urol; 1989 Oct; 142(4):1024-6. PubMed ID: 2795725
[TBL] [Abstract][Full Text] [Related]
2. Doxepin therapy for duodenal ulcer: a controlled trial in patients who failed to respond to cimetidine.
Shrivastava RK; Siegal H; Lawlor R; Shah BK; Dayican G
Clin Ther; 1985; 7(3):319-26. PubMed ID: 3888393
[TBL] [Abstract][Full Text] [Related]
3. Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials.
Nijman RJ; Borgstein NG; Ellsworth P; Djurhuus JC
J Urol; 2005 Apr; 173(4):1334-9. PubMed ID: 15758796
[TBL] [Abstract][Full Text] [Related]
4. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity.
Ginsberg D; Gousse A; Keppenne V; Sievert KD; Thompson C; Lam W; Brin MF; Jenkins B; Haag-Molkenteller C
J Urol; 2012 Jun; 187(6):2131-9. PubMed ID: 22503020
[TBL] [Abstract][Full Text] [Related]
5. Doxepin and cimetidine in the treatment of duodenal ulcer: a double-blind comparative study.
Shrivastava RK; Shah BK; Siegal H
Clin Ther; 1985; 7(2):181-9. PubMed ID: 3886141
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind study of electrical stimulation for urinary incontinence due to detrusor overactivity.
Yamanishi T; Yasuda K; Sakakibara R; Hattori T; Suda S
Urology; 2000 Mar; 55(3):353-7. PubMed ID: 10699609
[TBL] [Abstract][Full Text] [Related]
8. Terodiline in the treatment of women with urgency and motor urge incontinence. A clinical and urodynamic double-blind cross-over study.
Gerstenberg TC; Klarskov P; Ramirez D; Hald T
Br J Urol; 1986 Apr; 58(2):129-33. PubMed ID: 3516296
[TBL] [Abstract][Full Text] [Related]
9. Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial.
Ghei M; Maraj BH; Miller R; Nathan S; O'Sullivan C; Fowler CJ; Shah PJ; Malone-Lee J
J Urol; 2005 Nov; 174(5):1873-7; discussion 1877. PubMed ID: 16217327
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
[TBL] [Abstract][Full Text] [Related]
11. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.
Silva C; Silva J; Ribeiro MJ; Avelino A; Cruz F
Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of tramadol in the treatment of idiopathic detrusor overactivity: a double-blind, placebo-controlled, randomized study.
Safarinejad MR; Hosseini SY
Br J Clin Pharmacol; 2006 Apr; 61(4):456-63. PubMed ID: 16542207
[TBL] [Abstract][Full Text] [Related]
13. Terodiline, emepronium bromide or placebo for treatment of female detrusor overactivity? A randomised, double-blind, cross-over study.
Andersen JR; Lose G; Nørgaard M; Stimpel H; Andersen JT
Br J Urol; 1988 Apr; 61(4):310-3. PubMed ID: 3289675
[TBL] [Abstract][Full Text] [Related]
14. Biofeedback training for detrusor overactivity in children.
Yamanishi T; Yasuda K; Murayama N; Sakakibara R; Uchiyama T; Ito H
J Urol; 2000 Nov; 164(5):1686-90. PubMed ID: 11025748
[TBL] [Abstract][Full Text] [Related]
15. Terodiline: a dose titrated, multicenter study of the treatment of idiopathic detrusor instability in women.
Tapp A; Fall M; Norgaard J; Massey A; Choa R; Carr T; Korhonen M; Abrams P
J Urol; 1989 Oct; 142(4):1027-31. PubMed ID: 2677410
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of effectiveness of and tolerance to oxybutynin in the treatment of unstable bladder in women].
Serrano Brambila EA; Quiroga Avila RG; Lorenzo Monterrubio JL; Moreno Aranda J
Ginecol Obstet Mex; 2000 Apr; 68():174-81. PubMed ID: 10824450
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study.
Werner M; Schmid DM; Schüssler B
Am J Obstet Gynecol; 2005 May; 192(5):1735-40. PubMed ID: 15902187
[TBL] [Abstract][Full Text] [Related]
18. Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity?
Haylen BT; Chetty N; Logan V; Schulz S; Verity L; Law M; Zhou J
Int Urogynecol J Pelvic Floor Dysfunct; 2007 Feb; 18(2):123-8. PubMed ID: 16823541
[TBL] [Abstract][Full Text] [Related]
19. Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder.
Haab F; Stewart L; Dwyer P
Eur Urol; 2004 Apr; 45(4):420-9; discussion 429. PubMed ID: 15041104
[TBL] [Abstract][Full Text] [Related]
20. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
